tirzepatide latham Eli Lilly weight loss drug data released Eli Lilly's Tirzepatide Shows Promise

The New England Journal of Medicine, 384(11), 989-1002

Think of it as a tool in your wellness toolboxused carefully and thoughtfully by our experienced team to support real, lasting results

At the same time, the presence of the peptide has been shown to inhibit the production of a secretion known as somatostatin

F., Davis B

It also suggests that reducing intake of HFCS and beer, except for some purine-free brands that have become available in Japan, might be beneficial

But after Lilly's pill produced less weight loss than analysts had expected in a recent late-stage trial, it raised new questions about how widely the oral drugs will be adopted and which rival company will dominate the space